ArticleOphthalmology science2026

Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa.

Bill Bunnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.